The Mechanism by Which Safflower Yellow Decreases Body Fat Mass and Improves Insulin Sensitivity in HFD-Induced Obese Mice
- PMID: 27242533
- PMCID: PMC4876777
- DOI: 10.3389/fphar.2016.00127
The Mechanism by Which Safflower Yellow Decreases Body Fat Mass and Improves Insulin Sensitivity in HFD-Induced Obese Mice
Abstract
Objectives: Safflower yellow (SY) is the main effective ingredient of Carthamus tinctorius L. It has been reported that SY plays an important role in anti-inflammation, anti-platelet aggregation, and inhibiting thrombus formation. In present study, we try to investigate the effects of SY on body weight, body fat mass, insulin sensitivity in high fat diet (HFD)-induced obese mice.
Methods: HFD-induced obese male ICR mice were intraperitoneally injected with SY (120 mg kg(-1)) daily. Eight weeks later, intraperitoneal insulin tolerance test (IPITT), and intraperitoneal glucose tolerance test (IPGTT) were performed, and body weight, body fat mass, serum insulin levels were measured. The expression of glucose and lipid metabolic related genes in white adipose tissue (WAT) were determined by RT-qPCR and western blot technologies.
Results: The administration obese mice with SY significantly reduced the body fat mass of HFD-induced obese mice (P < 0.05). IPITT test showed that the insulin sensitivity of SY treated obese mice were evidently improved. The mRNA levels of insulin signaling pathway related genes including insulin receptor substrate 1(IRS1), PKB protein kinase (AKT), glycogen synthase kinase 3β (GSK3β) and forkhead box protein O1(FOXO1) in mesenteric WAT of SY treated mice were significantly increased to 1.9- , 2.8- , 3.3- , and 5.9-folds of that in HFD-induced control obese mice, respectively (P < 0.05). The protein levels of AKT and GSK3β were also significantly increased to 3.0 and 5.2-folds of that in HFD-induced control obese mice, respectively (P < 0.05). Meanwhile, both the mRNA and protein levels of peroxisome proliferator-activated receptorgamma coactivator 1α (PGC1α) in inguinal subcutaneous WAT of SY group were notably increased to 2.5 and 3.0-folds of that in HFD-induced control obese mice (P < 0.05).
Conclusions: SY significantly reduce the body fat mass, fasting blood glucose and increase insulin sensitivity of HFD-induced obese mice. The possible mechanism is to promote the browning of subcutaneous WAT and activate the IRS1/AKT/GSK3β pathway in visceral WAT. Our study provides an important experimental evidence for developing SY as a potential anti-obesity and anti-diabetic drug.
Keywords: PGC1α; insulin sensitivity; insulin signaling pathway; obesity; safflower yellow (SY).
Figures





Similar articles
-
Pharmacological Activities of Safflower Yellow and Its Clinical Applications.Evid Based Complement Alternat Med. 2022 Jun 27;2022:2108557. doi: 10.1155/2022/2108557. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35795285 Free PMC article. Review.
-
Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.Naunyn Schmiedebergs Arch Pharmacol. 2022 May;395(5):579-591. doi: 10.1007/s00210-022-02220-8. Epub 2022 Feb 24. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35201390
-
Safflower yellow improves insulin sensitivity in high-fat diet-induced obese mice by promoting peroxisome proliferator-activated receptor-γ2 expression in subcutaneous adipose tissue.J Diabetes Investig. 2020 Nov;11(6):1457-1469. doi: 10.1111/jdi.13285. Epub 2020 Jun 5. J Diabetes Investig. 2020. PMID: 32356607 Free PMC article.
-
Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice.Front Physiol. 2018 Feb 7;9:62. doi: 10.3389/fphys.2018.00062. eCollection 2018. Front Physiol. 2018. PMID: 29467670 Free PMC article.
-
Safflower Yellow and Its Main Component HSYA Alleviate Diet-Induced Obesity in Mice: Possible Involvement of the Increased Antioxidant Enzymes in Liver and Adipose Tissue.Front Pharmacol. 2020 Apr 21;11:482. doi: 10.3389/fphar.2020.00482. eCollection 2020. Front Pharmacol. 2020. PMID: 32372961 Free PMC article.
Cited by
-
Herbal Medicine for the Treatment of Obesity: An Overview of Scientific Evidence from 2007 to 2017.Evid Based Complement Alternat Med. 2017;2017:8943059. doi: 10.1155/2017/8943059. Epub 2017 Sep 25. Evid Based Complement Alternat Med. 2017. PMID: 29234439 Free PMC article. Review.
-
Pharmacological Activities of Safflower Yellow and Its Clinical Applications.Evid Based Complement Alternat Med. 2022 Jun 27;2022:2108557. doi: 10.1155/2022/2108557. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35795285 Free PMC article. Review.
-
The Repression of the HMGB1-TLR4-NF-κB Signaling Pathway by Safflower Yellow May Improve Spinal Cord Injury.Front Neurosci. 2021 Dec 24;15:803885. doi: 10.3389/fnins.2021.803885. eCollection 2021. Front Neurosci. 2021. PMID: 35002613 Free PMC article. Review.
-
Intragastric safflower yellow and its main component HSYA improve leptin sensitivity before body weight change in diet-induced obese mice.Naunyn Schmiedebergs Arch Pharmacol. 2022 May;395(5):579-591. doi: 10.1007/s00210-022-02220-8. Epub 2022 Feb 24. Naunyn Schmiedebergs Arch Pharmacol. 2022. PMID: 35201390
-
Safflower yellow improves insulin sensitivity in high-fat diet-induced obese mice by promoting peroxisome proliferator-activated receptor-γ2 expression in subcutaneous adipose tissue.J Diabetes Investig. 2020 Nov;11(6):1457-1469. doi: 10.1111/jdi.13285. Epub 2020 Jun 5. J Diabetes Investig. 2020. PMID: 32356607 Free PMC article.
References
-
- Barbatelli G., Murano I., Madsen L., Hao Q., Jimenez M., Kristiansen K., et al. . (2010). The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298, E1244–E1253. 10.1152/ajpendo.00600.2009 - DOI - PubMed
-
- Choi C. S., Savage D. B., Abu-Elheiga L., Liu Z. X., Kim S., Kulkarni A., et al. . (2007). Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc. Natl. Acad. Sci. U.S.A. 104, 16480–16485. 10.1073/pnas.0706794104 - DOI - PMC - PubMed
-
- Collins S., Daniel K. W., Petro A. E., Surwit R. S. (1997). Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology 138, 405–413. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous